Healthy Inc > Blog > generic Toradol supplier
Posted on:

What is ketorolac 60 mg used for?

Pharmaceutical Product Monograph: Ketorolac Tromethamine Injection (60 mg/2 mL)

In the pharmaceutical industry, Ketorolac Tromethamine is a high-potency, parenteral Non-Steroidal Anti-Inflammatory Drug (NSAID) of the pyrrolizine carboxylic acid derivative group. As a pharmacist and manufacturer, I view this molecule as a “Non-Opioid Analgesic Powerhouse”—it is technically designed to provide short-term pain relief with an efficacy profile comparable to low-dose Morphine or Meperidine, but without the respiratory depression or addiction potential.

At your WHO-GMP facility in Mumbai, Ketorolac 60 mg/2 mL is a critical Post-Operative and Trauma Care SKU. The 60 mg dose is specifically a Single-Dose loading or treatment dose for acute, severe pain management.

Therapeutic Profile: Primary Indications

Ketorolac is indicated only for the short-term (up to 5 days) management of moderately severe acute pain.

IndicationClinical ContextTechnical Rationale
Post-Surgical PainOrthopedic / GynecologicalOpioid Sparing: Used immediately after major surgery to reduce the need for narcotics.
Acute Renal ColicEmergency / UrologyHighly effective at inhibiting the prostaglandins that cause ureteral spasms and intense kidney stone pain.
Acute TraumaER / CasualtyProvides rapid stabilization for fractures or severe soft-tissue injuries before definitive surgery.
Migraine (Refractory)NeurologyUsed in the ER to terminate severe “status migrainosus” when other agents fail.

Mechanism: Potent COX-1 & COX-2 Inhibition

Ketorolac works by shutting down the “Biological Pain Transmitters” (Prostaglandins):

Enzyme Blockade: It non-selectively inhibits Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) enzymes.

Prostaglandin Suppression: It prevents the synthesis of $PGE_2$ and $PGF_{2\alpha}$, which normally sensitize peripheral pain receptors (nociceptors).

Peripheral Action: Unlike opioids, which act on the brain, Ketorolac technically acts at the site of injury, making it an excellent “peripheral” analgesic.

The Pharmacist’s “Technical Warning”

  • The “5-Day Limit”: As a pharmacist, I must emphasize that Ketorolac is not for chronic use. Continuing treatment beyond 5 days technically spikes the risk of life-threatening gastric perforation and acute renal failure.

  • The “Bleeding” Alert: Ketorolac is a potent inhibitor of platelet aggregation. It should be used with extreme caution in “bloody” surgeries (like tonsillectomy) or in patients on blood thinners, as it increases the risk of post-operative hemorrhage.

  • Renal Threshold: It is contraindicated in patients with moderate-to-severe renal impairment ($SCr > 1.4 \text{ mg/dL}$) or those at risk of volume depletion/dehydration.

  • The “Loading Dose” Clarification: While 60 mg is common as a single IM dose, for patients $>65$ years old or weighing $<50 \text{ kg}$, the maximum single dose is technically capped at 30 mg.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Stability & pH” USP: Ketorolac is highly sensitive to light and requires a precise pH (6.9 to 7.9). On your digital marketplace, highlight your Oxygen-Free Nitrogen Flushing and Amber Type 1 Glass vials. This ensures the solution stays clear and prevents the formation of “related substances” like ketorolac dimers.

  • The “NSAID-Opioid” Replacement Market: For international B2B tenders (especially in regions fighting the “Opioid Crisis” like North America and Europe), market Ketorolac as a “Narcotic-Sparing Essential.” It is a high-volume procurement item for modern pain clinics.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Ketorolac 30 mg/mL and 60 mg/2 mL to support your registration in international B2B tenders for surgical centers.

Posted on:

What are ketorolac injections used for?

Pharmaceutical Product Monograph: Ketorolac Tromethamine Injection (30 mg/mL)

In the pharmaceutical industry, Ketorolac Tromethamine is a high-potency Non-Steroidal Anti-Inflammatory Drug (NSAID) of the pyrrolizine carboxylic acid group. As a pharmacist and manufacturer, I view this molecule as the “Non-Opioid Heavyweight”—it is technically designed to provide analgesic efficacy comparable to morphine or meperidine but without the respiratory depression or addiction potential associated with narcotics.

At your WHO-GMP facility in Mumbai, Ketorolac 30 mg/mL (1 mL or 2 mL ampoules) is a premium SKU for Surgery and Emergency Medicine portfolios. It is strictly a short-term intervention designed to bridge the gap between intense acute pain and recovery.

Therapeutic Profile: Primary Indications

Ketorolac injection is indicated for the short-term (up to 5 days) management of moderately severe acute pain that requires analgesia at the opioid level.

IndicationClinical ContextTechnical Rationale
Post-Operative PainMajor SurgeryOpioid Sparing: Used after abdominal, orthopedic, or gynecological surgery to reduce the requirement for morphine.
Renal ColicKidney StonesProstaglandin Inhibition: Reduces the intense ureteral pressure and inflammation caused by stones.
Acute TraumaEmergency ERProvides rapid relief for fractures or severe soft tissue injuries without clouding the patient’s consciousness.
Migraine (Severe)NeurologyOften used in the ER as part of a “Migraine Cocktail” to terminate status migrainosus.

Mechanism: Potent COX Inhibition

Ketorolac works by shutting down the “Pain Signaling Factory” in the peripheral tissues:

Enzyme Blockade: It is a non-selective inhibitor of Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).

Prostaglandin Suppression: It prevents the conversion of arachidonic acid into Prostaglandins, which are the chemical messengers that sensitize pain receptors (nociceptors).

Peripheral Action: Unlike opioids, which work on the brain/CNS, Ketorolac stops the pain signal at the site of injury or surgery.

Tromethamine Salt: The “Tromethamine” part of the molecule is a buffer that technically increases the drug’s solubility and ensures rapid absorption into the bloodstream.

The Pharmacist’s “Technical Warning”

  • The “5-Day Rule”: As a pharmacist, I must emphasize that Ketorolac is not for chronic pain. Use beyond 5 days is technically linked to a massive increase in the risk of Gastrointestinal Bleeding and Acute Renal Failure.

  • The “Platelet” Warning: Ketorolac inhibits platelet aggregation. It must be used with extreme caution in post-operative patients where surgical bleeding (hemostasis) is a concern.

  • IV vs. IM: It can be given via Intramuscular (IM) or Intravenous (IV) bolus. When given IV, it should be administered over at least 15 seconds to avoid local vein irritation.

  • The “NSAID Ceiling”: Giving Ketorolac with other NSAIDs (like Ibuprofen or Naproxen) provides no extra pain relief but technically doubles the risk of stomach ulcers.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Stability” USP: Ketorolac is sensitive to Light and Oxygen. On your digital marketplace, highlight your Nitrogen-Purged Amber Ampoules. This is a technical requirement to prevent the solution from turning yellow-brown and losing potency (USP limit is usually 90–110%).

  • The “Opioid Alternative” Market: In 2026, the global B2B market is shifting toward “Multi-Modal Analgesia.” Market Ketorolac as a “Narcotic-Sparing Essential” to international surgical centers looking to reduce opioid-related complications like nausea and constipation.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Ketorolac 30 mg/mL ampoules to support your registration in international B2B tenders for surgery and emergency care.

Posted on:

What is the use of Ketorol 10 mg tablet?

In the pharmaceutical industry, Ketorol 10 mg (Ketorolac Tromethamine) is a high-potency, non-steroidal anti-inflammatory drug (NSAID) used for short-term management of acute, severe pain. As a pharmacist and manufacturer, I view it as a “Non-Opioid Analgesic Bridge”—it is one of the few NSAIDs with an analgesic efficacy comparable to low-dose morphine, but it lacks the addictive potential of narcotics.

At your WHO-GMP facility in Mumbai, where technical precision and safety are paramount, positioning this molecule correctly is essential. It is vital to emphasize that this is not a routine painkiller for minor aches, but a specialized drug for intense, post-procedural pain.

Therapeutic Profile: Primary Indications

Ketorol 10 mg is indicated exclusively for the short-term treatment of moderate to severe acute pain that requires analgesia at the opioid level.

IndicationTechnical Rationale
Post-Surgical PainFrequently used following dental, orthopedic, or gynecological surgeries.
Acute Renal ColicHighly effective in relaxing the ureter and reducing the intense inflammation caused by kidney stones.
Opioid SparingUsed in combination with opioids to reduce the total narcotic dose needed, thereby minimizing respiratory depression and constipation.
Limitation of UseStrictly limited to 5 days. Prolonged use exponentially increases the risk of renal failure and GI bleeding.

Mechanism: Potent Prostaglandin Inhibition

Ketorolac works by shutting down the chemical “pain messengers” at the source:

COX Inhibition: It is a non-selective inhibitor of the enzymes Cyclooxygenase-1 (COX-1) and COX-2.

Prostaglandin Blockade: By inhibiting these enzymes, it prevents the synthesis of prostaglandins, which are the primary mediators of peripheral pain, fever, and inflammation.

Analgesic Superiority: Its high affinity for COX enzymes allows it to provide intense pain relief without the sedative effects associated with opioids.

The Pharmacist’s “Technical Warning”

  • The “5-Day Rule”: As a pharmacist, I must stress that Ketorolac is contraindicated for chronic pain. Use beyond 5 days is a “hard stop” in clinical practice due to severe gastric and renal toxicity.

  • Renal Guard: It is contraindicated in patients with advanced renal impairment or those at risk for renal failure due to volume depletion.

  • GI Hemorrhage: Ketorolac has one of the highest risks of gastrointestinal bleeding among NSAIDs. It must be used with extreme caution in the elderly and those with a history of ulcers.

  • Bleeding Risk: It inhibits platelet aggregation. It should not be used as a prophylactic analgesic before major surgery or in patients with high bleeding risks.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Analgesic Alternative” USP: On your digital marketplace, position Ketorol 10 mg as the premier alternative to narcotics for surgical centers. In 2026, with the global focus on reducing opioid dependency, Ketorolac is a high-demand SKU for international hospital tenders.

  • Stability for Export: Ketorolac Tromethamine is sensitive to light. Utilizing Amber-colored blisters or Opaque Alu-Alu packaging is mandatory for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international hospital procurement systems and ministry of health (MOH) registries.

Ketorolac Tablets

Posted on:

Is ketorolac safe while breastfeeding?

In the pharmaceutical industry, Ketorolac Tromethamine is a highly potent Non-Steroidal Anti-Inflammatory Drug (NSAID). As a pharmacist and manufacturer, I classify this as a “Short-Term Rescue” analgesic.

According to the WHO and the American Academy of Pediatrics, Ketorolac is generally considered compatible with breastfeeding.

At your WHO-GMP facility in Mumbai, you likely manufacture this in 10 mg tablets and 30 mg/mL injections.

Safety Profile for Lactation

  • Low Milk Transfer: Ketorolac is excreted into breast milk in very small amounts.

  • Relative Infant Dose (RID): The amount an infant receives via milk is estimated to be less than 0.2% to 0.4% of the weight-adjusted maternal dose, which is far below the 10% safety threshold.

  • Short Half-Life: Because the drug is cleared relatively quickly (half-life of ~5 hours), it does not tend to accumulate in the mother or the infant.

Mechanism: Potent COX Inhibition

Ketorolac provides “opioid-level” pain relief without the sedative side effects.

Enzyme Targeting: It is a non-selective inhibitor of COX-1 and COX-2 enzymes.

Prostaglandin Blockade: By stopping the synthesis of prostaglandins at the site of injury, it shuts down the pain and inflammatory response.

B2B USP: In your digital marketing, you can highlight that Ketorolac is particularly effective for post-operative pain (such as after a C-section), allowing mothers to remain alert while managing severe pain.

The Pharmacist’s “Technical Warning”

As you build your firm’s authority online, these warnings are critical for clinical safety:

  • The 5-Day Rule: Ketorolac is strictly for short-term use (up to 5 days). Prolonged use significantly increases the risk of gastric ulcers and renal failure.

  • Infant Monitoring: While safe, the infant should be monitored for rare side effects like GI upset or unusual bruising.

  • Contraindication: It should be avoided if the mother or infant has a history of NSAID-induced asthma or significant renal impairment.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint at your Mumbai facility:

  • The “Injection to Tablet” Bridge: Highlight your ability to supply both IV/IM Vials and Oral Tablets. This “bridge therapy” is the standard of care in international hospitals for post-surgical recovery.

  • Stability & Packaging: Ketorolac is light-sensitive. We utilize Amber-colored glass for injections and Alu-Alu blister packaging for tablets to ensure a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international hospital tenders.

Ketorolac Tablets

Add to cart